Partnering with Health Systems to Enhance Diverse Patient Access in Trials

Using specific trials as examples, Dr Chetan Karyekar shares how Janssen Immunology is partnering with academic and community health systems to enhance diversity in clinical trials through recruitment strategies, outreach to local institutions, engaging in market research and building trustworthiness. Speaker: Chetan Karyekar, MD, PhD, VP, Clinical Development — Rare Diseases & Rheumatology, Janssen